Emtek Group Sells Stake of KlikDokter to Kalbe Farma
Kalbe has been the major shareholder of KlikDokter since the beginning, it is now owns 99.98% of the stake
Healthtech company KlikDokter is now fully owned by Kalbe Farma after taking 23.81% shares from Emtek Group's subsidiary, PT Kreatif Media Karya (KMK). Since the beginning, Kalbe, through PT Karsa Lintas Buwana (KLB), has been the major shareholder of 76.19% in KlikDokter when Emtek entered in 2016.
According to the disclosure on IDX, the transaction was completed on September 30, 2021, worth of IDR 62.5 billion. PT Medika Komunika Teknologi (MKT) which is the owner of KlikDokter service approved the decision to sell all shares or a total of 1,000 series B shares owned by KMK, each of 999 series B shares to KLB and 1 share to PT Hexpharm Jaya Laboratories (HJ) .
After the exchange, the latest composition is KLB with 99.98% ownership as follows, a total of 1000 series A shares or the equivalent of 23.81%; a total of 3,199 series B shares or the equivalent of 76.71%; and HJ with 1 share of series B or the equivalent of 0.02%.
Already have an account? Login
Not ready to subscribe yet? Purchase and access this article
Subscribe to keep reading and get unlimited premium article access with all subscription benefit
Subscribe and get:
- Access to premium article
- Download paid research
- Premium newsletter
- Ads free
Choose your subscription period:
Rp 150,000 /month
Pay for a month
- Rp 450,000
Rp 350,000 /quarter
Pay for 3 months
- Rp 1,800,000
Rp 1,033,000 /year
Pay for a year
Sign up for our
newsletter